WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60


Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :
Dr. Muhammad Baqir MR Fakhrildin
Download Article: Click Here


Track Your Article



Ghizlane BERRADA EL AZIZI1*, Samir AHID1, Saadia ABIR-KHALIL2, Fedoua ELLOUALI3, Mohammed CHERTI3, Abdelali BOUKILI4, Mohammed HASSAR1, Yahia CHERRAH1

1Research Team of Pharmacoepidemiology & Pharmacoeconomics. Laboratory of Pharmacology & Toxicology, Faculty of Medicine & Pharmacy, University Mohammed V- Souissi, Rabat, Morocco.
2Department of Cardiology. Clinic Agdal. Rabat, Morocco.
3Department of Cardiology B. University Hospital Ibn Sina. Rabat, Morocco.
4Department of Cardiology, military hospital of armed Mohammed V, 11000 Rabat, Morocco.


Purpose: High blood pressure (HBP) is a major public health problem in Morocco. The purpose of this study is to evaluate prescribing in actual practice among cardiologists, following therapeutic recommendations and to analyze the role of different therapeutic classes. Methods: This is an observational study conducted between November 2010 and May 2012, including 1223 outpatients with essential HBP followed at cardiology centers. We have retained the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) definition and classification of hypertension. Results: We recruited 1223 hypertensive patients of which 71% (n=868) had complicated hypertension. Monotherapy was prescribed for 25% of the hypertensive patients. The most prescribed therapeutic classes in monotherapy were angiotensin II receptor blockers (ARBs, 41.5%), angiotensin converting enzyme inhibitors (ACEI, 24.8%), calcium channel blockers (CCBs, 22.5%), diuretics (5.9%) and beta-blockers (β-blockers, 5.2%). More than 51% of patients received a dual therapy with 59.24% receiving a fixed combination of antihypertensive agents. The prescription of a triple therapy concerned 18.1%, while only 5.2% received quadruple therapy. The prescription of the β-blockers was more frequent in hypertensive patients with coronary artery disease, heart failure and heart rhythm disorders. The ACEI were prescribed more frequently in hypertensive patient with diabetes, with coronary artery diseases, heart failure, a stroke, or renal impairment. Conclusion: Therapeutic classes used in the treatment of hypertension are varied. The diuretics, CCBs and ARBs are the most prescribed and β-blockers the least prescribed. Complicated HBP leads to preferential prescription of diuretics, ARBs and CCBs.

Keywords: Hypertension, Antihypertensive, Ambulatory consultation

[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More